EFFECTS OF THE GLUCAGON-LIKE PEPTIDE-1 (GLP-1) ANALOGUES SEMAGLUTIDE AND LIRAGLUTIDE ON RENAL OUTCOMES - A POOLED ANALYSIS OF THE SUSTAIN 6 AND LEADER TRIALS

被引：0

作者：

Perkovic, Vlado ^{[1
]}

Bain, Stephen ^{[2
]}

Bakris, George ^{[3
]}

Buse, John ^{[4
]}

Idorn, Thomas ^{[5
]}

Mahaffey, Kenneth ^{[6
]}

Marso, Steven ^{[7
]}

Nauck, Michael ^{[8
]}

Pratley, Richard ^{[9
]}

Rasmussen, Soren ^{[5
]}

Rossing, Peter ^{[10
,11
]}

Tornoe, Karen ^{[5
]}

Zinman, Bernard ^{[12
]}

Mann, Johannes ^{[13
]}

机构：

[1] UNSW Sydney, George Inst Global Hlth, Sydney, NSW, Australia

[2] Swansea Univ, Sch Med, Swansea, W Glam, Wales

[3] Univ Chicago Med, Chicago, IL USA

[4] Univ N Carolina, Sch Med, Chapel Hill, NC 27515 USA

[5] Novo Nordisk AS, Site Soborg, Soborg, Denmark

[6] Stanford Sch Med, Stanford Ctr Clin Res, Stanford, CA 94305 USA

[7] Res Med Ctr, Kansas City, KS USA

[8] Ruhr Univ Bochum, St Josef Hosp, Diabet Ctr Bochum Hattingen, Bochum, Germany

[9] AdventHlth Translat Res Inst Metab & Diabet, Orlando, FL USA

[10] Steno Diabet Ctr Copenhagen, Gentofte, Denmark

[11] Univ Copenhagen, Copenhagen, Denmark

[12] Univ Toronto, Lunenfeld Tanenbaum Res Inst, Mt Sinai Hosp, Toronto, ON, Canada

[13] Friedrich Alexander Univ Erlangen, Erlangen, Germany

来源：

NEPHROLOGY DIALYSIS TRANSPLANTATION | 2019年 / 34卷

关键词：

D O I：

暂无

中图分类号：

R3 [基础医学]; R4 [临床医学];

学科分类号：

1001 ; 1002 ; 100602 ;

摘要：

SaO010

引用

页码：338 / 338

页数：1

共 50 条

[21] GLUCAGON-LIKE PEPTIDE-1 (GLP-1) - A PIECE OF THE INCRETIN PUZZLE
WEIR, GC
JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (01): : 1 - 1
[22] Potential Role of Glucagon-Like Peptide-1 (GLP-1) in Neuroprotection
Hoelscher, Christian
CNS DRUGS, 2012, 26 (10) : 871 - 882
[23] Potential Role of Glucagon-Like Peptide-1 (GLP-1) in Neuroprotection
Christian Hölscher
CNS Drugs, 2012, 26 : 871 - 882
[24] Effect of glucagon-like peptide-1 (GLP-1) analogues on epicardial adipose tissue: A meta-analysis
Berg, Gabriela
Barchuk, Magali
Lobo, Martin
Nogueira, Juan Patricio
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2022, 16 (09)
[25] The glucagon-like peptide-1 (GLP-1) analog liraglutide attenuates renal fibrosis (vol 131, pg 102, 2018)
Li, Ya-Kun
Ma, Dong-Xia
Wang, Zhi-Min
Hu, Xiao-Fan
Li, Shang-Lin
Tian, Hong-Zhe
Wang, Meng-Jun
Shu, Yan-Wen
Yang, Jun
PHARMACOLOGICAL RESEARCH, 2018, 135 : 269 - 270
[26] Glucagon-like peptide 1 (GLP-1)
Mueller, T. D.
Finan, B.
Bloom, S. R.
D'Alessio, D.
Drucker, D. J.
Flatt, P. R.
Fritsche, A.
Gribble, F.
Grill, H. J.
Habener, J. F.
Holst, J. J.
Langhans, W.
Meier, J. J.
Nauck, M. A.
Perez-Tilve, D.
Pocai, A.
Reimann, F.
Sandoval, D. A.
Schwartz, T. W.
Seeley, R. J.
Stemmer, K.
Tang-Christensen, M.
Woods, S. C.
DiMarchi, R. D.
Tschoep, M. H.
MOLECULAR METABOLISM, 2019, 30 : 72 - 130
[27] Novel skeletal effects of glucagon-like peptide-1 (GLP-1) receptor agonists
Mabilleau, Guillaume
Pereira, Marie
Chenu, Chantal
JOURNAL OF ENDOCRINOLOGY, 2018, 236 (01) : R29 - R42
[28] Gastrointestinal effects of glucagon-like peptide-1 (GLP-1): Mechanism of action.
Holst, JJ
Wojdemann, M
Wettergren, A
DIABETES, 1996, 45 : 859 - 859
[29] Glucagon-like peptide-1 (GLP-1) analogues: A potential new treatment for alcohol use disorder?
Fink-Jensen, Anders
Vilsboll, Tina
NORDIC JOURNAL OF PSYCHIATRY, 2016, 70 (08) : 561 - 562
[30] Insulin as a feedback regulator of glucagon-like peptide-1 (GLP-1) release?
Brunn, C
Schloos, J
Lemansky, P
Sewing, S
Mest, HJ
BRITISH JOURNAL OF PHARMACOLOGY, 1999, 128 : U59 - U59

← 1 2 3 4 5 →